You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: October 31, 2024

List of Excipients in API pitavastatin


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing pitavastatin

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Lupin Pharmaceuticals Inc NIKITA pitavastatin 68180-742 HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
Lupin Pharmaceuticals Inc NIKITA pitavastatin 68180-742 HYPROMELLOSE 2910
Lupin Pharmaceuticals Inc NIKITA pitavastatin 68180-742 LACTOSE MONOHYDRATE
Lupin Pharmaceuticals Inc NIKITA pitavastatin 68180-742 MAGNESIUM STEARATE
Lupin Pharmaceuticals Inc NIKITA pitavastatin 68180-742 SILICON DIOXIDE
Lupin Pharmaceuticals Inc NIKITA pitavastatin 68180-742 SODIUM BICARBONATE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Sign Up

Excipients in ANDA-approved (generic) drugs containing pitavastatin

Company Ingredient NDC Excipient
Mylan Pharmaceuticals Inc pitavastatin 0378-5055 HYPROMELLOSE
Mylan Pharmaceuticals Inc pitavastatin 0378-5055 LACTOSE MONOHYDRATE
Mylan Pharmaceuticals Inc pitavastatin 0378-5055 LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
Mylan Pharmaceuticals Inc pitavastatin 0378-5055 MAGNESIUM OXIDE
Mylan Pharmaceuticals Inc pitavastatin 0378-5055 MAGNESIUM STEARATE
Mylan Pharmaceuticals Inc pitavastatin 0378-5055 POLYETHYLENE GLYCOL 400
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for pitavastatin

Excipient focus: CALCIUM CARBONATE

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CROSPOVIDONE

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED

Excipient focus: HYPROMELLOSE

pitavastatin drug variants containing HYPROMELLOSE

Company Ingredient NDC
Mylan Pharmaceuticals Inc pitavastatin 0378-5055
Upsher-Smith Laboratories LLC pitavastatin calcium 0832-6048
Kowa Pharmaceuticals America Inc pitavastatin calcium 66869-104
Medicure International Inc pitavastatin magnesium 25208-201
Cadila Healthcare Limited pitavastatin magnesium 70771-1116
Zydus Lifesciences Limited pitavastatin magnesium 70771-1117
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE

Excipient focus: MAGNESIUM ALUMINOMETASILICATE TYPE I-B

pitavastatin drug variants not containing MAGNESIUM ALUMINOMETASILICATE TYPE I-B

Company Ingredient NDC
Mylan Pharmaceuticals Inc pitavastatin 0378-5055
Aurobindo Pharma Limited pitavastatin 65862-812
Lupin Pharmaceuticals Inc pitavastatin 68180-742
Teva Pharmaceuticals Inc pitavastatin calcium 0480-3632
Upsher-Smith Laboratories LLC pitavastatin calcium 0832-6048
Camber Pharmaceuticals Inc pitavastatin calcium 31722-875
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: MAGNESIUM ALUMINOMETASILICATE TYPE IB

pitavastatin drug variants not containing MAGNESIUM ALUMINOMETASILICATE TYPE IB

Company Ingredient NDC
Mylan Pharmaceuticals Inc pitavastatin 0378-5055
Amneal Pharmaceuticals LLC pitavastatin 65162-029
Lupin Pharmaceuticals Inc pitavastatin 68180-742
Teva Pharmaceuticals Inc pitavastatin calcium 0480-3632
Upsher-Smith Laboratories LLC pitavastatin calcium 0832-6048
Camber Pharmaceuticals Inc pitavastatin calcium 31722-875
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: MAGNESIUM CARBONATE

Excipient focus: MAGNESIUM OXIDE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: POLYETHYLENE GLYCOL

pitavastatin drug variants containing POLYETHYLENE GLYCOL

Company Ingredient NDC
Upsher-Smith Laboratories LLC pitavastatin calcium 0832-6048
Zydus Pharmaceuticals USA Inc pitavastatin calcium 68382-481
Zydus Lifesciences Limited pitavastatin calcium 70771-1784
Medicure International Inc pitavastatin magnesium 25208-201
Cadila Healthcare Limited pitavastatin magnesium 70771-1116
Zydus Lifesciences Limited pitavastatin magnesium 70771-1117
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOLS

Excipient focus: POLYSORBATE 80

Excipient focus: POVIDONE K30

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM BICARBONATE

Excipient focus: SODIUM CARBONATE

pitavastatin drug variants containing SODIUM CARBONATE

Company Ingredient NDC
Camber Pharmaceuticals Inc pitavastatin calcium 31722-875
Zydus Pharmaceuticals USA Inc pitavastatin calcium 68382-481
Zydus Lifesciences Limited pitavastatin calcium 70771-1784
Medicure International Inc pitavastatin magnesium 25208-201
Cadila Healthcare Limited pitavastatin magnesium 70771-1116
Zydus Lifesciences Limited pitavastatin magnesium 70771-1117
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

Excipient focus: TALC

pitavastatin drug variants containing TALC

Company Ingredient NDC
Upsher-Smith Laboratories LLC pitavastatin calcium 0832-6048
Zydus Pharmaceuticals USA Inc pitavastatin calcium 68382-481
QUINN PHARMACEUTICALS LLC pitavastatin calcium 69076-030
Zydus Lifesciences Limited pitavastatin calcium 70771-1784
Medicure International Inc pitavastatin magnesium 25208-201
Cadila Healthcare Limited pitavastatin magnesium 70771-1116
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIACETIN

Excipient focus: TRIETHYL CITRATE

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group